Transactivation and reactivation capabilities of temperature-dependent p53 mutants in yeast and human cells

International Journal of Oncology

Volumn 41, Issue 3, 2012, Pages 1157-1163

  Jagosova, Jana ^a,b   Pitrova, Lenka ^a,b   Slovackova, Jana ^a   Ravcukova, Barbora ^c   Smarda, Jan ^b   Smardova, Jana ^a,b  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

^c CENTRE FOR CARDIOVASCULAR SURGERY AND TRANSPLANTATION   (Czech Republic)

Author keywords

Discriminating p53 mutants; Functional analysis of separated alleles in yeast; p53; Temperature dependent p53 mutants; Transactivation

Indexed keywords

AMIFOSTINE; PROTEIN P53;

ARTICLE; ENZYME REACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE; TRANSACTIVATION; YEAST;

AMIFOSTINE; GENES, P53; HUMANS; MUTATION; RADIATION-PROTECTIVE AGENTS; TEMPERATURE; TRANSCRIPTIONAL ACTIVATION; TRANSFORMATION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; YEASTS;

EID: 84865025982     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1520     Document Type: Article

References (31)

1. Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P and Olivier M: Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 28: 622-629, 2007. (Pubitemid 46744292)
2. Blagosklonny MV: P53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect. FASEB J 14: 1901-1907, 2000.
3. Resnick MA and Inga A: Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity. Proc Natl Acad Sci USA 100: 9934-9939, 2003. (Pubitemid 37087046)
4. Monti P, Ciribilli Y, Jordan J, Menichini P, Umbach DM, Resnick MA, Luzatto L, Inga A and Fronza G: Transcriptional Functionality of germ line p53 mutants infuences cancer phenotype. Clin Cancer Res 13: 3789-3795, 2007. (Pubitemid 47037583)
5. Varley JM, McGown G, Thorncroft M, James LA, Margison GP, Forster G, Evans DGR, Harris M, Kelsey AM and Birch JM: Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors. Am J Hum Genet 65: 995-1006, 1999. (Pubitemid 30462956)
6. Ribeiro RC, Sandrini F, Figueiredo B, Zambetti GP, Michalkiewicz E, Lafferty AR, DeLacerda L, Rabin M, Cadwell C, Sampaio G, et al: An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci USA 98: 9330-9335, 2001. (Pubitemid 32743916)
7. Zambetti GP: The p53 mutation 'gradient effect' and its clinical implications. J Cell Physiol 213: 370-373, 2007.
8. Kato S, Han SY, Liu W, Otsuka K, Shibata H, Kanamura R and Ishioka C: Understanding the function-structure and function-mutation relatiohship of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci USA 100: 8424-8429, 2003. (Pubitemid 36842561)
9. Olivier M, Hollstein M and Hainaut P: TP53 mutations in human cancers: Origins, consequences, and clinical use. Cold Spring Harb Perspect Biol 2: a001008, 2010.
10. North S, Pluquet O, Maurici D, El-Ghissassi F and Hainaut P: Restoration of wild-type conformation and activity of a temperature-sensitive mutant of p53 (p53(V272M)) by the cytoprotective aminothiol WR1065 in the esophageal cancer cell line TE-1. Mol Carcinog 33: 181-188, 2002. (Pubitemid 34195199)
11. Maurici D, Monti P, Campomenosi P, North S, Frebourg T, Fronza G and Hainaut P: Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay. Oncogene 20: 3533-3540, 2001. (Pubitemid 32619406)
12. Di Como C and Prives C: Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in yeast-based assay. Oncogene 19: 2527-2539, 1998. (Pubitemid 28258584)
13. Bullock AN, Henckel J and Fersht AR: Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy. Oncogene 19: 1245-1256, 2000. (Pubitemid 30160617)
14. Shiraishi K, Kato S, Han SY, Liu W, Otsuka K, Sakayori M, Ishida T, Takeda M, Kanamaru R, Ochuchi N and Ishioka C: Isolation of temperature- sensitive p53 mutations from a comprehensive missense mutation library. J Biol Chem 279: 348-355, 2004. (Pubitemid 38044833)
15. Dearth LR, Qian H, Wang T, Baroni TE, Zeng J, Chen SW, Yi SY and Brachmann RK: Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers. Carcinogenesis 28: 289-298, 2007. (Pubitemid 46321844)
16. Joerger AC and Fersht AR: Structure-function-rescue: the diverse nature of common p53 cancer mutants. Oncogene 26: 2226-2242, 2007. (Pubitemid 46536643)
17. Grochova D, Vankova J, Damborsky J, Ravcukova B, Smarda J, Vojtesek B and Smardova J: Analysis of transactivation capability and conformation of p53 temperature-dependent mutants and their reactivation by amifostine in yeast. Oncogene 27: 1243-1252, 2008. (Pubitemid 351294697)
18. Slovackova J, Grochova D, Navratilova J, Smarda J and Smardova J: Transactivation by temperature-dependent p53 mutants in yeast and human cells. Cell Cycle 9: 2141-2148, 2010.
19. Ishioka C, Frebourg T, Yan Yx, Vidal M, Friend SH, Schmidt S and Iggo R: Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nat Genet 5: 124-129, 1993. (Pubitemid 23293446)
20. Flaman JM, Frebourg T, Moreau V, Charbonnier F, Martin C, Chappuis P, Sappino AP, Limacher JM, Bron L, Benhattar J, et al: A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci USA 92: 3963-3967, 1995.
21. Smardova J, Nemajerova A, Trbusek M, Vagunda V and Kovarik J: Rare somatic p53 mutation identified in breast cancer: a case report. Tumor Biol 22: 59-66, 2001. (Pubitemid 32010738)
22. Friedlander P, Haupt Y, Prives C and Oren M: A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol Cell Biol 16: 4961-4971, 1996. (Pubitemid 26272151)
23. Navratilova J, Horvath V, Kozubik A, Lojek A, Lipsick J and Smarda J: p53 arrest growth and induces differentiation of v-Myb-transformed monoblasts. Differentiation 75: 592-604, 2007. (Pubitemid 47301596)
24. Pavlova S, Mayer J, Koukalova H and Smardova J: High frequency of temperature-sensitive mutations of p53 tumor suppressor in acute myeloid leukemia revealed by functional assay in yeast. Int J Oncol 23: 121-131, 2003.
25. Campomenosi P, Monti P, Aprile A, Abbondandolo A, Frebourg T, Gold B, Crook T, Inga A, Resnick MA, Iggo R and Fronza G: p53 mutants can ften transactivate promoters containing a p21 but not Bax or PIG3 responsive elements. Oncogene 20: 3573-3579, 2001. (Pubitemid 32619411)
26. Flaman JM, Robert V, Lenglet S, Moreau V, Iggo R and Frebourg T: Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assay in yeast. Oncogene 16: 1369-1272, 1998.
27. Inga A, Monti P, Fronza G, Darden T and Resnick M: p53 mutants exhibiting enhanced transcriptional activation and altered promoter selectivity are revealed using a sensitive, yeast-based functional assay. Oncogene 20: 501-513, 2001. (Pubitemid 32158230)
28. Fulci G, Ishii N, Maurici D, Gernert KM, Hainaut P, Kaur B and Van Metr EG: Initiation of human astrocytoma by clonal evolution of cells with progressive los sof p53 functions in a patient with a 283H TP53 germ-line mutation: Evidence for precursor lesion. Cancer Res 62: 2897-2905, 2002. (Pubitemid 34525777)
29. Hansen S, Hupp TR and Lane DP: Allosteric regulation of the thermostability and DNA binding activity of human p53 by specific interacting proteins. J Biol Chem 271: 3917-3924, 1996. (Pubitemid 26065715)
30. Xirodimas DP and Lane DP: Molecular evolution of the thermosensitive PAb1620 epitope of human p53 by DNA shuffling. J Biol Chem 274: 28042-28049, 1999.
31. Cho Y, Gorina S, Jeffrey PD and Pavletich NP: Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265: 346-355, 1994. (Pubitemid 24259959)